090430
XKRX
Market cap6.36bUSD
Nov 20, Last price
139,400.00KRW
1D
-2.18%
1Q
1.01%
Jan 2017
-56.64%
IPO
-86.06%
Name
AmorePacific Corp
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Amorepacific Corporation is a global enterprise engaged in the manufacturing and sale of beauty, household, and healthcare merchandise. The company's extensive offerings include a wide range of skincare products, such as cleansers, toners, hydrating fluids, moisturizers, eye treatments, concentrated serums, facial masks, and specialized care or travel-sized items. They also provide solutions for various skin concerns, including anti-aging, dryness, improving tone and texture, sun protection, and a diverse selection of makeup products. Founded in 1945, its main operational base is located in Seoul, South Korea.
Key people
Seung Hwan Kim
Co-Chief Executive Officer, Director · since 2023
Chairman, Co-Chief Executive Officer · since 2013
Yeong Su Kim
Managing Director · since 2017
Yeong Gil Cho
Head of Digital Technology Operation Division · since 2022
Geung Hyeon Cho
Head of Shanghai Business Division · since 2023
Yun Seong Choi
Head of Laneige Global Marketing Division · since 2024
Myeong Jong Choi
Head of SCP Division · since 2022
Jae Wuk Hong
Head of New Commerce Division · since 2022
Seong Bong Hong
Head of Digital Technology Development Division · since 2022
Yeong Min Hwang
Head of Management Planning Division
Hyo Jeong Joo
Head of Digital Strategy Division
Hye Jin Jung
Head of Sulwhasoo Brand Unit · since 2023
Chang Wuk Jung
Head of Development & Purchase Division · since 2022
Myeong Gu Kang
Head of SCM Unit · since 2024
Wang Gi Kim
Head of HBD Research Division · since 2022
Ha Yeon Kim
Head of Body & Dental Division
Jeong Yeon Kim
Head of Sulwhasoo Global Marketing Division
Yeong Ho Kim
Head of Management Strategy Division · since 2025
Yeong So Kim
Head of Quality Safety Research Division · since 2022
Yeong Su Kim
Head of APAC RHQ · since 2022
Valuation
Title KRW in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||